Literature DB >> 1477928

Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.

Y Watanabe1, Y Matsumoto, K Kawamoto, S Yazawa, M Matsumoto.   

Abstract

The absorption of insulin (from porcine pancreas) in rabbits after the nasal administration of aqueous preparations containing insulin and five kinds of cyclodextrins (CyDs) in phosphate buffer solution at pH 7.0 was investigated. Without CyD, the insulin and glucose levels in plasma were unchanged, whereas a marked increase in the plasma levels of insulin and a decrease in glucose concentrations were observed following the simultaneous administration of insulin and CyD such as alpha- and heptakis (2,6-di-O-methyl)-beta-CyD (DM-beta-CyD). The largest enhancing effect on the nasal absorption of insulin was obtained by DM-beta-CyD. To evaluate the duration of the absorption-enhancing effect of CyDs, preadministration (administration of CyD 0.5, 6, 12 and 24 h before insulin administration) was performed. The area under plasma concentration-time curve (AUC) and Cmax of insulin significantly decreased with the preadministration of DM-beta-CyD 6, 12 and 24 h before nasal administration. The absorption-enhancing effect disappeared 24h after the preadministration. These findings demonstrate that CyDs enhance the nasal absorption of insulin, and the recovery of the membrane transport barrier function in nasal mucosa is achieved, at the latest, 24 h after the administration of CyDs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477928     DOI: 10.1248/cpb.40.3100

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.

Authors:  Z Shao; Y Li; T Chermak; A K Mitra
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

2.  Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins.

Authors:  L Hovgaard; H Brøndsted
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

3.  Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies.

Authors:  Tianzhi Yang; Alamdar Hussain; Jennifer Paulson; Thomas J Abbruscato; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.